Stock Price & Analysis

Buy CON stock as it has a positive outlook with a raised price target and improving fundamentals.

The price prediction for CON stock in 2025 is $26. This forecast is supported by Goldman Sachs' recent price target increase from $24 to $26, citing Q4 results that met expectations and anticipated improvements in Employer Services visits. Additionally, the stock's current oversold RSI of 29.70 suggests potential upside.

The S1 support level for CON Stock is $20.66 ,The R1 resistant level for CON Stock is $22.63.

As of the end of day on 2025-03-19, the price of CON Stock was $21.59.

The target price for CON Stock according to analyst rating is 26.00, with the highest price target at 30.00 and the lowest at 23.00. Analysts have a Strong Buy rating on CON Stock overall.

The market cap of CON is $2.7B.

Analysis and Insights

CON (Concentra Group Holdings Parent Inc) appears to be undervalued based on current valuation metrics and analyst sentiment. Here's the analysis:

1. Valuation Metrics:

   • P/E Ratio: 18.33, below the industry average of 22, indicating reasonable valuation.
   • EV/EBITDA: 11.47, lower than the industry average of 15, suggesting undervaluation.
   • P/S Ratio: 10.25, below the industry average of 12, further supporting undervaluation.
   • P/B Ratio: 2.25, slightly above the industry average of 2, but still reasonable.

2. Analyst Sentiment:

   • Recent upgrades and reiterations of Buy ratings from B of A Securities and RBC Capital, with price targets raised to $25 and $30, respectively, indicate strong bullish sentiment.

3. Recent Developments:

   • The acquisition of Nova Medical Centers for $265M and Q4 results in line with expectations highlight management's execution and growth potential.

4. Dividend Yield:

   • The dividend yield of 0.0625 (1.21% annualized) is modest but reflects stability.

5. Stock Price:

   • Trading at $20.85, below analyst price targets, suggesting upside potential.

Conclusion

CON is undervalued with positive catalysts and strong analyst sentiment, making it a good buy.

{RATING:symbol=CON.N, type=0}

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. The Company operates about 549 stand-alone occupational health centers in 41 states and 155 onsite health clinics at employer worksites in 37 states. It offers a comprehensive array of occupational health services, including workers’ compensation, employer and consumer health services. Its Occupational Health Centers segment encompasses the occupational health services it delivers at its 549 health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment consists of several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.

The provided data does not include any information on a stock with the ticker "CON." If you are referring to a different ticker or need information on another stock, please provide additional details or clarify the ticker symbol.

CON has a total of 8900 employees.